Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
=Anti-CD20-based regimen= | =Anti-CD20-based regimen= | ||
| + | =EGFR TKI therapy= | ||
=Endocrine-based regimen= | =Endocrine-based regimen= | ||
Revision as of 00:14, 11 January 2020
The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.